Modifications to Product Sample Clauses

Modifications to Product. (a) Buyer may, from time to time and with reasonable prior notice, direct Supplier to manufacture additional Product, which is not New Product, or to modify existing Product specifications, recipes, formulas and processes. Supplier shall be responsible for implementing manufacturing and supply changes required to accommodate such Product proposals. (b) Subject to Section 2.3, Supplier shall not change any specifications, recipes, formulas, or processes related to Product without Buyer's prior approval. (c) Buyer shall have the right to audit and approve all changes to standard costs reflected in the Bills of Materials, including but not limited to, changes in formulae, processes, ingredients, ▇▇▇▇▇▇▇ per line, line speeds and yields, structural waste, and units per Case (including any change to a ▇▇▇▇ of Materials whereby an operating variance is reclassified into ongoing direct cost). In addition, Buyer shall have the right to audit the transition to any new information system implemented by Supplier to assure the consistent treatment of Base Standard Costs and Updated Standard Costs and other concepts set forth herein. Subject to Section 3.5, Supplier shall be responsible for scaling up and implementing any manufacturing and supply changes required to accommodate any changes to Product. (d) Any provision of this Section 4.1 to the contrary notwithstanding, if Buyer modifies existing Product specifications, recipes, formulas or process, Buyer shall purchase, or cause to be purchased, Supplier's entire inventory of a discontinued Product Code and any ingredients and packaging made obsolete by the discontinuation of such a Product Code; provided, however, that Buyer shall not be obligated to purchase such obsolete inventories or ingredients or packaging in excess of twenty-five percent (25%) of the volume of such ingredients or packaging which has been consumed or used by Supplier in manufacturing such discontinued Product Code during the twelve (12) months immediately preceding its discontinuance.
Modifications to Product. Sophos may in its sole discretion modify or update the Product from time to time without materially reducing or degrading its overall functionality.
Modifications to Product. NJ Bid is continuously updating and changing the Product, and reserves the right at any time and from time to time to modify or discontinue, temporarily or permanently, the Product (or any part thereof) with or without notice. You agree that NJ Bid shall not be liable to you or to any third party for any modification, suspension or discontinuance of the Product (or any part thereof). Additionally, we reserve the right, in our complete and sole discretion, to change these terms of this agreement at any time by posting revised terms on the Product. It is your responsibility to check periodically for any changes we may make to the Product and this Agreement. Your continued use of this Product following the posting of changes to these terms or other policies means you accept the changes.
Modifications to Product. 1. Oscient reserves the right to modify, change, develop or improve the Product, including any change in the manufacturing process of the active pharmaceutical ingredient of the Product (the “Alteration”) during the Term of this Agreement and shall give Pfizer Mexico as much prior written notice as is reasonably practicable of any Alteration (for purposes of this Section 1(D)(1), the “Notice Period”); provided that, Oscient shall continue to deliver Product and the active pharmaceutical ingredient of the Product (in terms of Section 4 (c) (3)), during such Notice Period upon receipt of a Purchase Order (as defined in Section 4(A)(5)) from Pfizer Mexico pursuant to the Specifications in place prior to any Alteration. 2. Until termination of the Fill-Finish Supply Period (as defined below), Oscient shall give Pfizer Mexico as much prior written notice as is reasonable practicable of any amendment to the manufacturing process and packaging specification (for purposes of this Section 1(D)(2), the “Notice Period”); provided that, Oscient shall continue to deliver Product during such Notice Period upon receipt of a Purchase Order from Pfizer Mexico pursuant to the Specifications in place prior to any such amendment to the manufacturing process or packaging specifications.
Modifications to Product. Franchisee will not modify, amend, add to, decompile, disassemble, reverse engineer or otherwise alter the Product or the menu or menus of the Product without the prior written consent of Friendly's. Franchisee will not alter or remove any copyright notice or other notice of proprietary interest of Friendly's, the author or the owner of the Product. Franchisee shall not use the Product in connection or combination with software not provided or approved by Friendly's for the Product.
Modifications to Product. The following modifications to the Product will be made by NEI and included in the Manufacturing Package delivered to IBM under this license; a) NEI agrees to modify the Product mechanicals such that the hard-drives can be removed in the field by IBM service personnel. b) NEI agrees to reasonably support IBM in its modification of the Product bezel to meet IBM Industrial Design (ID) requirements. IBM acknowledges that all costs and expenses associated with such modification shall be the sole responsibility of IBM. c) NEI will make appropriate code changes to the BIOS (Subject to AMI approval, as applicable), POST, CMbus, FOS and diagnostics to replace all references to NEI in such items to references to IBM in accordance with IBM requirements. d) NEI will provide all currently-existing Product publications and allow IBM to modify them to meet IBM specifications. Currently available publications are (1) Hardware Specifications and (2) Install/Administrator Guide. In addition, (3) Procedures for Hard File Removal will also be provided by NEI. e) NEI will make any necessary changes to the Product design such that the Product meets worldwide agency certification requirements as specified in Attachment 1 Section E, below.